Centessa Pharmaceuticals plc (CNTA) Tops Q3 EPS by 12c
Tweet
Share
E-mail
Get Alerts CNTA Hot Sheet
Join SI Premium – FREE
Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q3 EPS of ($0.40), $0.12 better than the analyst estimate of ($0.52).
For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Twin Disc (TWIN) Tops Q4 EPS by 16c
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
